Categories
Coronavirus News

Impact of COVID-19 on Antibody-drug Conjugates Market by 2026|Trusted Business Insights

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Antibody-drug Conjugates market.

Trusted Business Insights presents an updated and Latest Study on Antibody-drug Conjugates Market 2020-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Antibody-drug Conjugates market during the forecast period (2020-2029).
It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Impact of COVID-19 on Antibody-drug Conjugates Market by 2026|Trusted Business Insights

A recently published report by Trusted Business Insights titled Global Antibody-drug Conjugates Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and its most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Antibody-drug Conjugates market. Trusted Business Insights report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.

Trusted Business Insights aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Report Overview:

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

The global Antibody-drug Conjugates market size is projected to reach US$ 3262.1 million by 2026, from US$ 2731.9 million in 2020, at a CAGR of 3.0% during 2021-2026.

The global Antibody-drug Conjugates market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibody-drug Conjugates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

North America ranks the top in terms of global market size of Antibody Drug Conjugate, it consists of 59.12% of the international market in 2016. Europe comes the second, with 27.70% of the global market. Asia Pacific consists of 6.54%of the Antibody Drug Conjugate market in the same year.

Geographical Analysis:

Based on region, the global Antibody-drug Conjugates market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.

Key Players:

The major players that are operating in the global Antibody-drug Conjugates market are:

Segment by Type

  • Adcetris
  • Kadcyla

Segment by Application

  • Breast Cancer
  • Lymphoma

Competitive Landscape:

Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Antibody-drug Conjugates market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.

The report covers the following objectives:

¢ Proliferation and maturation of trade in the global Antibody-drug Conjugates market.

¢ The market share of the global Antibody-drug Conjugates market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.

¢ Current and future market trends that are influencing the growth opportunities and growth rate of the global Antibody-drug Conjugates market.

¢ Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Antibody-drug Conjugates market.

Looking for more? Check out our repository for all available reports on Antibody-drug Conjugates in related sectors.

Quick Read Table of Contents of this Report @ Impact of COVID-19 on Antibody-drug Conjugates Market by 2026|Trusted Business Insights

Contacts

Trusted Business Insights
Shelly Arnold
Media & Marketing Executive
Email Me For Any Clarifications
Connect on LinkedIn
Click to follow Trusted Business Insights LinkedIn for Market Data and Updates.
US: +1 646 568 9797
UK: +44 330 808 0580

Categories
All News Coronavirus News

Antibody Drug Conjugates Market is projected to grow at an annualized rate of over 20%, till 2030

Roots Analysis has done a detailed report on Antibody Drug Conjugates Market, covering various important aspects of the industry and identifying key future growth opportunities.

To order this 600+ page report, which features 190+ figures and 280+ tables, please visit this link

Key Market Insights

  • Eminent representatives from different biopharmaceutical companies confirm the sustained interest in ADC therapeutics, highlighting the technological innovation that is driving contemporary R&D initiatives
  • Presently, over 240 ADC therapy candidates are being evaluated in clinical / preclinical stages for treating a variety of solid tumors / hematologic cancers
  • The pipeline features product candidates that target a wide range of biological antigens and are equipped with different cytotoxic warheads; a number of companies are focused on developing novel drug conjugates
  • In order to gain a competitive edge in the market, ADC developers are actively exploring new biological targets, conducting clinical trials across different geographies to treat diverse disease indications
  • A number of eminent scientists from renowned universities, owing to their involvement in clinical development efforts, have emerged as key opinion leaders within this market
  • Over the years, more than 16,000 patents related to ADCs have been filed / granted across the world, indicative of the ongoing pace of R&D activity in this field of research
  • Several investors, having realized the opportunity within this upcoming segment of targeted cancer therapeutics industry, have invested over USD 5 billion, in the period between 2011 and 2019
  • The increasing interest in this field is also reflected in the partnership activity; deals inked in the recent past were mostly focused on licensing of products / technologies, involving both international and indigenous stakeholders
  • In the recent years, several developer companies have initiated clinical trials to evaluate the therapeutic potential of ADCs in combination with other drug / therapy classes
  • Anticipating the launch of several product candidates, stakeholders are exploring diverse commercialization strategies across different stages of the launch cycle along with the appropriate reimbursement strategies
  • Given the complexities associated with the development and production of ADCs, CMOs are indispensable to the R&D and manufacturing activity in this domain; some CMOs have even pioneered the novel ADC technology platforms
  • Case Study: In order to keep patients and healthcare professionals informed and aware of the developments, companies are deploying diverse promotional strategies for their respective products
  • With a promising development pipeline and encouraging clinical results, the global market is anticipated to witness growth at an annualized rate of over 20% during the next decade
  • The anticipated future opportunity is likely to be distributed across different types of linkers and target antigens as more late-stage drugs get commercialized and existing marketing authorizations are expanded

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Table of Contents

  1. PREFACE
    • Scope of the Report
    • Research Methodology
    • Chapter Outlines
  2. EXECUTIVE SUMMARY
  3. INTRODUCTION
    • Chapter Overview
    • Evolution of Anticancer Therapy
    • Cancer Treatment Methods
      • Surgery
      • Radiation Therapy
      • Chemotherapy
      • Targeted Therapies
    • Monoclonal Antibody-Based Anticancer Therapies
    • Components of Antibody Drug Conjugates (ADCs)
      • Antibody
      • Cytotoxin
      • Linker
    • Advantages of ADC Therapeutics over Traditional Therapeutic Interventions
    • Differences Between Small Molecule Drugs, Monoclonal Antibody Therapies and ADCs
    • Pharmacokinetic Properties of ADCs
      • Absorption
      • Distribution
      • Metabolism and Excretion
  1. MARKET OVERVIEW
    • Chapter Overview
    • ADC Therapeutics: Clinical Pipeline
      • Analysis by Phase of Development
      • Analysis by Indication
      • Analysis by Line of Treatment
      • Analysis by Dosing Regimen
      • Analysis by Type of Therapy
      • Analysis by Target Antigen
      • Analysis by Antibody Origin
      • Analysis by Antibody Isotype
      • Analysis by Type of Linker
      • Analysis by Type of Payload / Warhead
      • Key Technology Providers
      • Discontinued Drugs
    • ADC Therapeutics: Preclinical Pipeline
      • Analysis by Phase of Development
      • Analysis by Indication
      • Analysis by Target Antigen
      • Key Players: Analysis by Number of ADC Therapeutics
    • ADC Therapeutics: Developer Landscape
      • Analysis by Year of Establishment
      • Analysis by Company Size
      • Analysis by Geographical Location
      • Logo Landscape: Analysis by Size and Target Indication
    • Novel Drug Conjugates
  2. COMPANY AND DRUG PROFILES
    • Chapter Overview
    • AbbVie
      • Company Overview
      • Financial Information
      • Pipeline Overview
        • Rovalpituzumab Tesirine / ROVA-T

5.2.3.1.1 Drug Overview

5.2.3.1.2. Mechanism of Action

5.2.3.1.3. Clinical Development Status

5.2.3.1.4. Key Clinical Trial Results

  • Teliso-V / Telisotuzumab Vedotin / ABBV-399

5.2.3.2.1 Drug Overview

5.2.3.2.2. Mechanism of Action

5.2.3.2.3. Clinical Development Status

5.2.3.2.4. Key Clinical Trial Results

  • Recent Developments and Future Outlook
  • Astellas Pharma
    • Company Overview
    • Financial Information
    • Pipeline Overview
      • Enfortumab Vedotin
        • Drug Overview
        • Mechanism of Action
        • Clinical Development Status
        • Key Clinical Trial Results
      • ASG16-M8F
        • Drug Overview
        • Mechanism of Action
        • Clinical Development Status
        • Key Clinical Trial Results
      • Recent Developments and Future Outlook
    • AstraZeneca

54.1. Company Overview

5.4.2. Financial Information

5.4.3. Pipeline Overview

5.4.3.1. LUMOXITI™

5.4.3.1.1. Drug Overview

5.4.3.1.2. Mechanism of Action

5.4.3.1.3. Clinical Development Status

5.4.3.1.4. Key Clinical Trial Results

5.4.4. Recent Developments and Future Outlook

  • Daiichi Sankyo
    • Company Overview
    • Financial Information
    • Pipeline Overview
      • Trastuzumab deruxtecan / DS-8201a / DS 8201
        • Drug Overview
        • Mechanism of Action
        • Clinical Development Status
        • Key Clinical Trial Results
      • Recent Developments and Future Outlook
    • ImmunoGen
      • Company Overview
      • Financial Information
      • Pipeline Overview
        • IMGN853 / Mirvetuximab soravtansine
          • Drug Overview
          • Mechanism of Action
          • Clinical Development Status
          • Key Clinical Trial Results
        • Recent Developments and Future Outlook
      • Immunomedics
        • Company Overview
        • Financial Information
        • Pipeline Overview
          • IMMU-130
            • Drug Overview
            • Mechanism of Action
            • Clinical Development Status
            • Key Clinical Trial Results
          • Recent Developments and Future Outlook
        • Pfizer
          • Company Overview
          • Financial Information
          • Pipeline Overview
            • CMC-544 / BESPONSA® / Inotuzumab Ozogamicin
              • Drug Overview
              • Mechanism of Action
              • Clinical Development Status
              • Key Clinical Trial Results
            • MYLOTARG™ / Gemtuzumab Ozogamicin
              • Drug Overview
              • Mechanism of Action
              • Clinical Development Status
              • Key Clinical Trial Results
            • Recent Developments and Future Outlook
          • Roche / Genentech
            • Company Overview
            • Financial Information
            • Pipeline Overview
              • KADCYLA®
                • Drug Overview
                • Mechanism of Action
                • Clinical Development Status
                • Key Clinical Trial Results
              • RG-7596
                • Drug Overview
                • Mechanism of Action
                • Clinical Development Status
                • Key Clinical Trial Results
              • Recent Developments and Future Outlook
            • Seattle Genetics
              • Company Overview
              • Financial Information
              • Pipeline Overview
                • ADCETRIS®
                  • Drug Overview
                  • Mechanism of Action
                  • Clinical Development Status
                  • Key Clinical Trial Results
                • SGN- LIV1A
                  • Drug Overview
                  • Mechanism of Action
                  • Clinical Development Status
                  • Key Clinical Trial Results
                • Recent Developments and Future Outlook
              • Synthon
                • Company Overview
                • Financial Information
                • Pipeline Overview
                  • SYD985 / Trastuzumab Duocarmazine
                    • Drug Overview
                    • Mechanism of Action
                    • Clinical Development Status
                    • Key Clinical Trial Results
                  • Recent Developments and Future Outlook
                • Other Companies
                  • Bayer HealthCare
                    • Company Overview
                    • Financial Information
                    • Pipeline Overview
                    • Recent Developments and Future Outlook
                  • Biotest Pharmaceuticals
                    • Company Overview
                    • Financial Information
                    • Pipeline Overview
                    • Recent Developments and Future Outlook
  1. KEY THERAPEUTIC AREAS
    • Chapter Overview
    • Hematological Malignancies
      • Leukemias and Lymphomas
        • Leukemia: Introduction and Epidemiology
          • Acute Myeloid Leukemia
          • Chronic Myeloid Leukemia
          • Acute Lymphocytic Leukemia
          • Chronic Lymphocytic Leukemia
        • Lymphoma: Introduction and Epidemiology
        • Current Treatment Landscape
        • ADC Therapeutics for Leukemia / Lymphoma
      • Multiple Myeloma
        • Introduction and Epidemiology
        • Current Treatment Landscape
        • ADC Therapeutics for Multiple Myeloma
      • Solid Tumors
        • Lung Cancer
          • Introduction and Epidemiology
          • Current Treatment Landscape
          • ADC Therapeutics for Lung Cancer
        • Breast Cancer
          • Introduction and Epidemiology
          • Current Treatment Landscape
          • ADC Therapeutics for Breast Cancer
        • Ovarian Cancer
          • Introduction and Epidemiology
          • Current Treatment Landscape
          • ADC Therapeutics for Ovarian Cancer
        • Bladder Cancer
          • Introduction and Epidemiology
          • Current Treatment Landscape
          • ADC Therapeutics for Bladder Cancer
        • Colorectal Cancer
          • Introduction and Epidemiology
          • Current Treatment Landscape
          • ADC Therapeutics for Colorectal Cancer
        • Prostate Cancer
          • Introduction and Epidemiology
          • Current Treatment Landscape
          • ADC Therapeutics for Prostate Cancer
        • Gastric Cancer
          • Introduction and Epidemiology
          • Current Treatment Landscape
          • ADC Therapeutics for Prostate Cancer
  1. KEY OPINION LEADERS
    • Chapter Overview
    • Methodology
    • Principal Investigators / Sub-Investigators / Study Directors Involved in Clinical Trials
      • Geographical Distribution of Key Opinion Leaders
        • Experts on ADCETRIS®
        • Experts on KADCYLA®
        • Experts on MYLOTARG™
        • Experts on Other ADCs
      • Prominent Key Opinion Leaders (KOLs)
      • KOL Benchmarking: Roots Analysis versus Third Party Scoring (ResearchGate Score)
      • Most Active Key Opinion Leaders
        • Profile: KOL A (Celgene)
        • Profile: KOL B (Western Regional Medical Center)
        • Profile: KOL C (MedStar Washington Hospital Center)
        • Profile: KOL D (Cancer Institute and Hospital)
        • Profile: KOL E (Comprehensive Cancer Centers of Nevada)
        • Profile: KOL F (Hopital Tenon)
        • Profile: KOL G (Cleveland Clinic)
  1. TARGET COMPETITIVENESS ANALYSIS
    • Chapter Overview
    • Scope and Methodology
    • Competitiveness Analysis: Key Clinical Targets for ADCs
      • Four-Dimensional Bubble Analysis

8.3.2 Five-Dimensional Spider Web Analysis

  • Competitiveness Analysis: Key Preclinical Targets for ADCs
    • Two-Dimensional Scatter Plot Analysis

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/antibody-drug-conjugates-market-5th-edition-2019-2030/270.html    

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Categories
News

Antibody Drug Conjugates Market Booming Demand Leading To Exponential CAGR Growth By 2026 | DataIntelo

Dataintelo, one of the world’s prominent market research firms has released a new report on Antibody Drug Conjugates market. The report is full of crucial insights on the market which will help the clients in making correct business decisions. This research will help both existing and new aspirants for Global Antibody Drug Conjugates Market to figure out and study market requirements, market size, and competition. The report talks about the supply and demand scenario, the competitive market scene, challenges for market growth, market opportunities, and the threats faced by key players.

The report is also integrated with the impact of the ongoing global crisis i.e. COVID-19 on the Antibody Drug Conjugates market and how the pandemic is tweaking the current situation. The published report is designed with the help of a vigorous and thorough research methodology. Dataintelo is also popular for its data accuracy and granular market reports. A complete picture of the competitive scenario of the Antibody Drug Conjugates market is presented by this report. The report has a substantial amount of data about the recent product and technological developments in the markets. It has a wide spectrum of analysis regarding the impact of these advancements on the market’s future growth, wide-range of analysis of these extensions on the market’s future growth.

Request a sample before buying this report @ https://dataintelo.com/request-sample/?reportId=80416

The report is molded by tracking market performance since 2015 and is one of the most detailed reports. It also consists of data varying according to region and country. The insights in the report are simple, easy to understand, and include pictorial representations. These insights are also applicable in real-time scenarios. Components such as market drivers, restraints, challenges, and opportunities for Antibody Drug Conjugates are explained in detail. Since the research team is tracking the data for the market from 2015, therefore any additional data requirement can be easily fulfilled.

You can buy the complete report @ https://dataintelo.com/checkout/?reportId=80416

Some of the prominent companies that are covered in this report:

F. Hoffman-La Roche
Novartis AG
Takeda Pharmaceutical
Pfizer
Seattle Genetics
Genentech
Immunogen
Progenics Pharmaceuticals
Bayer Healthcare Pharmaceuticals

*Note: Additional companies can be included on request

The industry seems to be evenly competitive. To analyze any market with simplicity the market is divided into segments, such as its product type, application, technology, end-use industry, etc. Segmenting the market into smaller components makes it easier in understanding the dynamics of the market with more transparency. Data is depicted with the help of tables and figures that consist of a graphical representation of the numbers in the form of histograms, bar graphs, pie charts, etc. Another key component that is integrated with the report is the regional analysis to assess the global presence of the Antibody Drug Conjugates market.

Following is the gist of segmentation:

By Application:

Breast Cancer
Lymphoma

By Type:

Adcetris
Kadcyla

By Geographical Regions

Asia Pacific: China, Japan, India, and Rest of Asia Pacific
Europe: Germany, the UK, France, and Rest of Europe
North America: The US, Mexico, and Canada
Latin America: Brazil and Rest of Latin America
Middle East & Africa: GCC Countries and Rest of Middle East & Africa

You can also go for a yearly subscription of all the updates on the Antibody Drug Conjugates market.

Reasons you should buy this report:

  • Dataintelo is keeping a track of the market since 2015 and has added the necessary historical data & analysis in the research report.
  • It also offers a complete assessment of the expected behavior about the future market and changing market scenario.
  • Making an informed business decision is a tough job; this report provides several strategic business methodologies to support you in making those decisions.
  • Industry experts and research analysts have worked extensively to prepare the research report which will help you to give that extra edge in the competitive market.
  • The market research report can be customized according to your needs. This means that Dataintelo can cover a particular product, application, or a company can provide a detailed analysis in the report. You can also purchase a separate report for a specific region.

Below is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Antibody Drug Conjugates Market Overview

Global Antibody Drug Conjugates Market Analysis and Forecast by Type

Global Antibody Drug Conjugates Market Analysis and Forecast by Application

Global Antibody Drug Conjugates Market Analysis and Forecast by Sales Channel

Global Antibody Drug Conjugates Market Analysis and Forecast by Region

North America Antibody Drug Conjugates Market Analysis and Forecast

Latin America Antibody Drug Conjugates Market Analysis and Forecast

Europe Antibody Drug Conjugates Market Analysis and Forecast

Asia Pacific Antibody Drug Conjugates Market Analysis and Forecast

Asia Pacific Antibody Drug Conjugates Market Size and Volume Forecast by Application

Middle East & Africa Antibody Drug Conjugates Market Analysis and Forecast

Competition Landscape

If you have any questions on this report, please reach out to us @ https://dataintelo.com/enquiry-before-buying/?reportId=80416

About Dataintelo:

Dataintelo has a vast experience in making tailored market research reports in a number of industry verticals. We also have an urge to provide complete client satisfaction. We cover in-depth market analysis, which consists of generating lucrative business strategies for the new entrants and the emerging players of the market. We make sure that each report is subjected to intensive primary, secondary research, interviews, and consumer surveys before final dispatch. Our company offers market threat analysis, market opportunity analysis, and deep insights into the current market scenario.

We invest in our analysts and take care of them to ensure that we have a full roster of experience and expertise in any field we cover. Our team members are selected for stellar academic records, specializations in technical fields, and exceptional analytical and communication skills. We also provide ongoing training and knowledge sharing to keep our analysts tapped into industry best practices and loaded with information.

Contact Info: –
Name: – Alex Mathews
Address: – 500 East E Street, Ontario,
CA 91764, United States.
Phone No: – USA: +1 909 545 6473
Email: – [email protected]
Website: – https://dataintelo

Categories
All News Coronavirus News

Antibody Drug Conjugates Market is projected to be worth more than USD 15 Billion by 2030, growing at a CAGR of over 20%

The growing popularity and therapeutic potential of antibody drug conjugates (ADCs) is evident in the rapid growth in intellectual capital, financing and partnership activity reported in the past five years

Roots Analysis has announced the addition of Antibody Drug Conjugates Market (5th Edition), 2019-2030 report to its list of offerings.

With six marketed drugs, ADCs are presently recognized as a potent class of targeted anticancer therapies, with the potential to be used to treat a variety of other disease indications. The success of such products can be attributed to their ability to effectively identify and eliminate disease associated cells / pathogens, with substantially lower risk of treatment related side effects.

To order this 600+ page report, which features 190+ figures and 280+ tables, please visit this link 

Key Market Insights 

Around 250 ADCs are currently under development  
Of these, nearly 40% are in the clinical phase of development, while the rest are in the preclinical / discovery stage. Presently, most of such therapeutic leads are being developed against the HER2 antigen; other popular biological targets include CD30 and EGFR.

60% of clinical stage therapy candidates are designed for the treatment of solid tumors
Within this segment, breast cancer (which represents a share of 22%) is currently the most popular target indication (in terms of number of therapy candidates in the pipeline), followed by non-small cell lung cancer (10%). ADC therapeutics are also being developed for hematological malignancies, such as multiple myeloma (31%), lymphoma (27%) and leukemia (27%).

More than 11,000 patents have been filed / granted related to ADCs and affiliated technologies, since 2015
Around 40% of these intellectual property documents were filed / granted in the US; other key regions with significant intellectual capital include China, Japan, Canada, Korea and Taiwan. Leading non industry players (in terms of the size of intellectual property portfolio) include INSERM, University of California, Leland Stanford Junior University and University of Pennsylvania.

USD 5+ billion has been invested by both private and public investors, till 2019
Around USD 2 billion was raised through venture capital financing alone, representing 40% of the total capital amount raised since 2011. Further, there have been six IPOs, from which companies claim to have raised over USD 1 billion in financing.

Partnership activity in this field has increased at an annualized rate of 30%    
In fact, around 60% of the deals considered in this analysis were established post 2015, the maximum activity being reported in 2018. Majority of these agreements (over 100) were observed to be either R&D agreements and / or licensing deals.

Over time, CMOs have become indispensable to the R&D and manufacturing activity in this domain
Presently, 30 CMOs have the required capabilities to manufacture and conjugate ADCs; of these, 50% claim to be one-stop-shops, providing end-to-end services across all steps of ADC manufacturing. Further, over 80% of ADC contract manufacturers are based in either North America or Europe with facilities dedicated to ADC manufacturing / conjugation located in one or multiple regions.

North America and Europe are anticipated to capture over 80% of the market share by 2030
It also worth noting that ADC products using VC linkers and SMCC linkers are likely to capture more than 60% of the market. Further, based on type of cytotoxic payload, ADCs using MMAE and DMI are anticipated to capture close to 50% of the overall market share.

To request a sample copy / brochure of this report, please visit this link    

Key Questions Answered

  • Who are the leading industry and non-industry players engaged in this market?
  • Who are the key ADC development and manufacturing technology providers?
  • What are the prevalent and upcoming trends related to ADC payload and linkers?
  • What are the new biologic target antigens being explored for ADC development?
  • Who are the key / emerging CMOs, in different regions, that you can reach out to for your manufacturing requirements?
  • Who are the key investors in the ADC market?
  • What are the most prominent drugs / therapies being currently used in combination with ADCs?
  • What kind of partnership models are commonly adopted by ADC developers / manufacturers?
  • Who are the key opinion leaders / experts who can support contemporary ADC development efforts?
  • How is the current and future market opportunity likely to be distributed across key market segments?
  • What kind of commercialization and promotional strategies are being used by ADC developers?

The USD 15 billion (by 2030) financial opportunity within this market has been analyzed across the following segments:

  • Type of Payload
    • MMAE
    • DM4
    • Camptothecin
    • DM1
    • MMAF
    • Others
  • Type of Linker
    • VC
    • Sulfo-SPDB
    • SMCC
    • VA
    • Hydrazone
    • Others
  • Target Indication
    • Breast cancer
    • Lymphoma
    • Leukemia
    • Urothelial cancer
    • Lung cancer
    • Ovarian cancer
    • Others
  • Target Antigen
    • CD30
    • HER2
    • CD22
    • CD33
    • Others
  • Technology Providers
    • Seattle Genetics
    • ImmunoGen
    • StemCentRx
    • Immunomedics
    • Others
  • Key Geographical Regions 
    • North America
    • Europe
    • Asia Pacific

The report features inputs from eminent industry stakeholders, according to whom upcoming generations of ADC therapeutics are likely to garner significant interest among therapy developers and end users alike. The report includes detailed transcripts of discussions held with the following experts:

  • Alan Burnett (Professor, School of Medicine, Cardiff University)
  • Aldo Braca (President and Chief Executive Officer) and Giorgio Salciarini (Technical Business Development Senior Manager, BSP Pharmaceuticals)
  • Anthony DeBoer (Director, Business Development, Synaffix)
  • Christian Bailly (Director of CDMO, Pierre Fabre)
  • Christian Rohlff, (Chief Executive Officer and Founder, Oxford BioTherapeutics)
  • Denis Angioletti (Chief Commercial Officer, Cerbios-Pharma)
  • John Burt (Chief Executive Officer, Abzena)
  • Jennifer L. Mitcham (Director, SMARTag ADCs and Bioconjugates) and Stacy McDonald (Group Product Manager, Catalent Pharma Solutions)
  • Laurent Ducry (Head of Bioconjugates Commercial Development, Lonza)
  • Mark Wright (Site Head, Piramal Healthcare)
  • Sasha Koniev (Chief Executive Officer & Co-Founder, Syndivia)
  • Tatsuya Okuzumi (Associate General Manager, Ajinomoto Bio-Pharma Services)
  • Toshimitsu Uenaka (Executive Director) and Takashi Owa (Chief Innovation Officer, Eisai)
  • Wouter Verhoeven (Chief Business Officer, NBE-Therapeutics)

The research covers elaborate profiles, featuring an overview of the company, its financial information (if available), detailed information on advanced stage pipeline candidates (featuring a drug overview, clinical development plan and key clinical trial results) and an informed future outlook. 

  • AbbVie
  • Astellas Pharma
  • AstraZeneca
  • Daiichi Sankyo
  • Pfizer
  • Roche / Genentech
  • Synthon
  • Bayer HealthCare
  • Biotest Pharmaceuticals

For additional details, please visit https://www.rootsanalysis.com/reports/view_document/antibody-drug-conjugates-market-5th-edition-2019-2030/270.html

or email [email protected] 

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
[email protected]

Categories
News

Growth Of Antibody Drug Conjugates Market In Global Industry: Overview, Size And Share 2020-2027

DataIntelo, one of the world’s prominent market research firms has announced a novel report on Global Antibody Drug Conjugates Market. The report contains vital insights on the market which will support the clients to make the right business decisions. This research will help both existing and new aspirants for Antibody Drug Conjugates market to figure out and study the market needs, market size, and competition. The report incorporates data regarding the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities, and the threats faced by key players during the forecast period of 2020-2027.

Get A Free Sample Report @ https://dataintelo.com/request-sample/?reportId=80416

Impact of COVID-19 on Antibody Drug Conjugates Market

The report also includes the impact of ongoing global crisis i.e. COVID-19 on the Antibody Drug Conjugates market and what the future holds for it. It provides an analysis of the effects of the pandemic on the global economy. The outbreak has directly disturbed the demand and supply chain. The report also analyzes the financial impact on firms and financial markets. DataIntelo has gathered insights from several delegates of the industry and got involved in the primary and secondary research to provide the clients with data and strategies to combat the market challenges during and after COVID-19 pandemic.

Benefits of buying the report:

  • The published report is compiled using a vigorous and thorough research methodology. DataIntelo is also known for its data accuracy and granular market reports.
  • A complete picture of the competitive scenario of Antibody Drug Conjugates market is depicted by this report.
  • The report consists of a vast amount of data about the recent product and technological developments in the markets.
  • The extensive spectrum of analysis regarding the impact of these advancements on the future of market growth.
  • DataIntelo is keeping a track of the market since 2015 and has blended the necessary historical data and analysis in the research report. Therefore, any additional data requirement can be easily fulfilled.
  • The insights in the report are easy to understand and include a graphical representation of the numbers in the form of histograms, bar graphs, pie charts, etc.
  • Components such as market drivers, restraints, challenges, and opportunities for Antibody Drug Conjugates market are explained in detail.
  • It also provides a complete assessment of the expected behavior about the future market and changing market scenario.
  • Making an informed business decision is a tough job; this report offers several strategic business methodologies to support you in making those decisions.

Industry experts and research analysts have worked extensively to prepare the research report which will help you to give that extra edge in the competitive market. The market research report can be customized according to you to your needs. This means that DataIntelo can cover a particular product, application, or can provide a detailed analysis in the report. You can also purchase a separate report for a specific region.

You can buy the complete report @ https://dataintelo.com/checkout/?reportId=80416

Some of the major companies that are covered in this report:

F. Hoffman-La Roche
Novartis AG
Takeda Pharmaceutical
Pfizer
Seattle Genetics
Genentech
Immunogen
Progenics Pharmaceuticals
Bayer Healthcare Pharmaceuticals

*Note: Additional companies can be included on request

The market scenario is likely to be fairly competitive. To analyze any market with simplicity the market is fragmented into the following segments:

By Application:

Breast Cancer
Lymphoma

By Type:

Adcetris
Kadcyla

By Geographical Regions

Asia Pacific: China, Japan, India, and Rest of Asia Pacific
Europe: Germany, the UK, France, and Rest of Europe
North America: The US, Mexico, and Canada
Latin America: Brazil and Rest of Latin America
Middle East & Africa: GCC Countries and Rest of Middle East & Africa

Segmenting the market into smaller components helps in analyzing the dynamics of the market with more clarity. Another key component that is included in the report is the regional analysis to assess the global presence of the Antibody Drug Conjugates market. You can also opt for a yearly subscription of all the updates on the Antibody Drug Conjugates market.

Request a sample before buying this report @ https://dataintelo.com/request-sample/?reportId=80416

Below is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Antibody Drug Conjugates Market Overview

Antibody Drug Conjugates Supply Chain Analysis

Antibody Drug Conjugates Pricing Analysis

Global Antibody Drug Conjugates Market Analysis and Forecast by Type

Global Antibody Drug Conjugates Market Analysis and Forecast by Application

Global Antibody Drug Conjugates Market Analysis and Forecast by Sales Channel

Global Antibody Drug Conjugates Market Analysis and Forecast by Region

North America Antibody Drug Conjugates Market Analysis and Forecast

Latin America Antibody Drug Conjugates Market Analysis and Forecast

Europe Antibody Drug Conjugates Market Analysis and Forecast

Asia Pacific Antibody Drug Conjugates Market Analysis and Forecast

Asia Pacific Antibody Drug Conjugates Market Size and Volume Forecast by Application

Middle East & Africa Antibody Drug Conjugates Market Analysis and Forecast

Competition Landscape

If you have any questions on this report, feel free to reach us! @ https://dataintelo.com/enquiry-before-buying/?reportId=80416

About DataIntelo:

DataIntelo has a vast experience in making customized market research reports in various industry verticals. Our motto is to provide complete client satisfaction. We cover in-depth market analysis, which consists of stipulating lucrative business strategies, especially for the new entrants and the emerging players of the market. We make sure that each report goes through intensive primary, secondary research, interviews, and consumer surveys before final dispatch.

We invest in our analysts to ensure that we have a full roster of experience and expertise in any field we cover. Our team members are selected for stellar academic records, specializations in technical fields, and exceptional analytical and communication skills. We also provide ongoing training and knowledge sharing to keep our analysts tapped into industry best practices and loaded with information.

Contact Info: –
Name: – Alex Mathews
Address: – 500 East E Street, Ontario,
CA 91764, United States.
Phone No: – USA: +1 909 545 6473
Email: – [email protected]
Website: – https://dataintelo

Categories
All News

Antibody-drug Conjugates Market In-deep Analysis And Healthcare Experts Review Report 2020-2025

The report discusses many vital industry facets that influence the “Global Antibody-drug Conjugates Market” industry acutely which includes extensive study of competitive edge, latest advancements, region-wise industry environment, contemporary market and emerging trends, leading market contenders, and current tendency of the end user. The report also oversees market size, market share, growth rate, revenue, and CAGR reported previously along with its forecast estimation.

Click Here to Get Sample PDF Copy of Latest Research on Antibody-drug Conjugates Market 2020:

https://www.marketintelligencedata.com/reports/119689/global-antibody-drug-conjugates-market-growth-2020-2025/inquiry?source=&mode=87

Global Antibody-drug Conjugates includes Market Analysis Report Top Companies: ImmunoGen,Seattle Genetics, Takeda, Roche

Segmented Types are:

Adcetris

    Kadcyla

Segmented Applications are:

Breast Cancer

    Lymphoma

Market Analysis and Status: Global Antibody-drug Conjugates Market:

-Since the COVID-19 virus outbreak in December 2019, the ailment has spread to just about 100 nations around the world with the World Health Organization pronouncing it a general health crisis. The worldwide effects of the coronavirus infection 2019 (COVID-19) are as of now beginning to be felt, and will significantly influence the Antibody-drug Conjugates Market in 2020.

-COVID-19 can influence the worldwide economy in three fundamental manners: by straightforwardly influencing creation and request, by supply chain and market interruption, and by its financial effect on firms and financial markets.

Scope Of The Report:

The research report on the global Antibody-drug Conjugates Market is a comprehensive publication that aims to identify the financial outlook of the market. For the same reason, it offers a detailed understanding of the competitive landscape. It studies some of the leading players, their management styles, their research and development statuses, and their expansion strategies. The report also includes product portfolios and the list of products in the pipeline. It includes a thorough explanation of the cutting-edging technologies and investments being made to upgrade the existing ones.

Regional Analysis For Antibody-drug Conjugates Market:

For comprehensive understanding of market dynamics, the global Antibody-drug Conjugates market is analyzed across key geographies namely: North AmericaEuropeChinaJapan, Southeast Asia, India, North America (USA, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) South America (Brazil, Argentina, Columbia, etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa).

Browse The Report Description And TOC:

https://www.marketintelligencedata.com/reports/119689/global-antibody-drug-conjugates-market-growth-2020-2025?source=&mode=87

Influence of the Antibody-drug Conjugates Market Report:

-Comprehensive assessment of all opportunities and risk in the Antibody-drug Conjugates market.

-Antibody-drug Conjugates market recent innovations and major events.

-Detailed study of business strategies for growth of the Antibody-drug Conjugates market-leading players.

-Conclusive study about the growth plot of Antibody-drug Conjugates market for forthcoming years.

-In-depth understanding of Antibody-drug Conjugates market-particular drivers, constraints and major micro markets.

-Favourable impression inside vital technological and market latest trends striking the Antibody-drug Conjugates market.

Finally, the Antibody-drug Conjugates Market Report is the authoritative source for market research that can dramatically accelerate your business. The report shows economic conditions such as major locales, item values, profits, limits, generation, supply, requirements, market development rates, and numbers.

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Note: All the reports that we list have been tracking the impact of COVID-19 on the market. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

About us:

Marketintelligencedata provides syndicated market research on industry verticals including Healthcare, Information, and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. Marketintelligencedata provides global and regional market intelligence coverage, a 360-degree market view that includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Sales Manager) – Market Intelligence Data

Phone: + 1704 266 3234

[email protected]

Categories
News

Antibody-drug Conjugates Market Insights, Status, Latest Amendments and Outlook 2019-2025

Up Market Research (UMR), one of the world’s prominent market research firms has announced a novel report on Global Antibody-drug Conjugates Market. The report contains vital insights on the market which will support the clients to make the right business decisions. This research will help both existing and new aspirants for Antibody-drug Conjugates market to figure out and study the market needs, market size, and competition. The report incorporates data regarding the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities, and the threats faced by key players during the forecast period of 2020-2026.

Get A Free Sample Report @ https://www.upmarketresearch.com/home/requested_sample/50062

Impact of COVID-19 on Antibody-drug Conjugates Market

The report also includes the impact of ongoing global crisis i.e. COVID-19 on the Antibody-drug Conjugates market and what the future holds for it. It provides an analysis of the effects of the pandemic on the global economy. The outbreak has directly disturbed the demand and supply chain. The report also analyzes the financial impact on firms and financial markets. Up Market Research (UMR) has gathered insights from several delegates of the industry and got involved in the primary and secondary research to provide the clients with data and strategies to combat the market challenges during and after COVID-19 pandemic.

Benefits of buying the report:

  • The published report is compiled using a vigorous and thorough research methodology. Up Market Research (UMR) is also known for its data accuracy and granular market reports.
  • A complete picture of the competitive scenario of Antibody-drug Conjugates market is depicted by this report.
  • The report consists of a vast amount of data about the recent product and technological developments in the markets.
  • The extensive spectrum of analysis regarding the impact of these advancements on the future of market growth.
  • Up Market Research (UMR) is keeping a track of the market since 2015 and has blended the necessary historical data and analysis in the research report. Therefore, any additional data requirement can be easily fulfilled.
  • The insights in the report are easy to understand and include a graphical representation of the numbers in the form of histograms, bar graphs, pie charts, etc.
  • Components such as market drivers, restraints, challenges, and opportunities for Antibody-drug Conjugates market are explained in detail.
  • It also provides a complete assessment of the expected behavior about the future market and changing market scenario.
  • Making an informed business decision is a tough job; this report offers several strategic business methodologies to support you in making those decisions.

Industry experts and research analysts have worked extensively to prepare the research report which will help you to give that extra edge in the competitive market. The market research report can be customized according to you to your needs. This means that Up Market Research (UMR) can cover a particular product, application, or can provide a detailed analysis in the report. You can also purchase a separate report for a specific region.

You can buy the complete report @ https://www.upmarketresearch.com/buy/antibody-drug-conjugates-market-research

Some of the major companies that are covered in this report:

ImmunoGen
Seattle Genetics
Roche
Takeda

*Note: Additional companies can be included on request

The market scenario is likely to be fairly competitive. To analyze any market with simplicity the market is fragmented into the following segments:

By Application:

Breast Cancer
Lymphoma

By Type:

Adcetris
Kadcyla

By Geographical Regions

Asia Pacific: China, Japan, India, and Rest of Asia Pacific
Europe: Germany, the UK, France, and Rest of Europe
North America: The US, Mexico, and Canada
Latin America: Brazil and Rest of Latin America
Middle East & Africa: GCC Countries and Rest of Middle East & Africa

Segmenting the market into smaller components helps in analyzing the dynamics of the market with more clarity. Another key component that is included in the report is the regional analysis to assess the global presence of the Antibody-drug Conjugates market. You can also opt for a yearly subscription of all the updates on the Antibody-drug Conjugates market.

Request a sample before buying this report @ https://www.upmarketresearch.com/home/requested_sample/50062

Below is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Antibody-drug Conjugates Market Overview

Antibody-drug Conjugates Supply Chain Analysis

Antibody-drug Conjugates Pricing Analysis

Global Antibody-drug Conjugates Market Analysis and Forecast by Type

Global Antibody-drug Conjugates Market Analysis and Forecast by Application

Global Antibody-drug Conjugates Market Analysis and Forecast by Sales Channel

Global Antibody-drug Conjugates Market Analysis and Forecast by Region

North America Antibody-drug Conjugates Market Analysis and Forecast

Latin America Antibody-drug Conjugates Market Analysis and Forecast

Europe Antibody-drug Conjugates Market Analysis and Forecast

Asia Pacific Antibody-drug Conjugates Market Analysis and Forecast

Middle East & Africa Antibody-drug Conjugates Market Analysis and Forecast

Competition Landscape

If you have any questions on this report, feel free to reach us! @ https://www.upmarketresearch.com/home/enquiry_before_buying/50062

About Up Market Research (UMR):

Up Market Research (UMR) has a vast experience in making customized market research reports in various industry verticals. Our motto is to provide complete client satisfaction. We cover in-depth market analysis, which consists of stipulating lucrative business strategies, especially for the new entrants and the emerging players of the market. We make sure that each report goes through intensive primary, secondary research, interviews, and consumer surveys before final dispatch.

We invest in our analysts to ensure that we have a full roster of experience and expertise in any field we cover. Our team members are selected for stellar academic records, specializations in technical fields, and exceptional analytical and communication skills. We also provide ongoing training and knowledge sharing to keep our analysts tapped into industry best practices and loaded with information.

Contact Info –
UpMarketResearch
Name – Alex Mathews
Email[email protected]
Websitehttps://www.upmarketresearch.com
Address – 500 East E Street, Ontario, CA 91764, United States.

Categories
All News

Antibody-drug Conjugates Market Size 2020 | Analysis, Trends, Top Manufacturers, Growth, Scope, Opportunities and Forecast to 2027

New Jersey, United States,- The Antibody-drug Conjugates Market report provides an in-depth analysis of the current and future state of the Antibody-drug Conjugates industry. The Antibody-drug Conjugates Market Report presents emerging trends and market dynamics regarding drivers, opportunities, and challenges. The report covers the details of suppliers, consumers, and the level of competition. It also includes Antibody-drug Conjugates Market Size, Revenue, Share, Industry Growth Rate, and Revenue. The Antibody-drug Conjugates market report has an essential list of key aspects of Antibody-drug Conjugates that includes leading market players along with their profiles and key financial data.

The most recent Antibody-drug Conjugates market report has extensive documentation of this industry while also showing the consumption and production patterns. The report provides information on key drivers, challenges, threats, and opportunities that are influencing market dynamics. It also includes Porter’s Five Forces Analysis to examine the industry’s competitive matrix.

The study draws attention to various trading tactics that can be used to generate returns. However, due to the recent COVID-19 outbreak, the market will have some uncertainties. The research, therefore, focuses on the impact of the coronavirus pandemic on the industry scenario over the forecast period and suggests a coping mechanism for better results.

The report provides an in-depth analysis of the major market players along with their business overview, expansion plans, and strategies. The main actors examined in the report are:

  • ImmunoGen
  • Seattle Genetics
  • Roche
  • Takeda

    The report covers the global Antibody-drug Conjugates Market size in terms of value chain, production and consumption quota. The report considers 2017-2018 as historical years, 2019 as the base year and the forecast calendar 2020-2027. It also covers the market breakdown in terms of top manufacturers, key regions, types of products offered in the market and range of applications.

    Antibody-drug Conjugates Market by Type Segments:

  • Adcetris
  • Kadcyla

    Antibody-drug Conjugates Market by Application Segments:

  • Breast Cancer
  • Lymphoma

    Antibody-drug Conjugates Market by Regional Segments:

    The chapter on regional segmentation details the regional aspects of the Antibody-drug Conjugates market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and anticipates its influence on the Antibody-drug Conjugates market.

    • The Middle East and Africa (GCC Countries and Egypt)
    • North America (the United States, Mexico, and Canada)
    • South America (Brazil etc.)
    • Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
    • Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

    Report Highlights

    • Comprehensive pricing analysis on the basis of product, application, and regional segments
    • The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the Antibody-drug Conjugates market
    • Deep insights about regulatory and investment scenarios of the Antibody-drug Conjugates market
    • Analysis of market effect factors and their impact on the forecast and outlook of the Antibody-drug Conjugates market
    • A roadmap of growth opportunities available in the Antibody-drug Conjugates market with the identification of key factors
    • The exhaustive analysis of various trends of the Antibody-drug Conjugates market to help identify market developments

    Table of Contents

    • Report Overview: It includes six chapters, viz. research scope, major manufacturers covered, market segments by type, Antibody-drug Conjugates market segments by application, study objectives, and years considered.
    • Global Growth Trends: There are three chapters included in this section, i.e. industry trends, the growth rate of key producers, and production analysis.
    • Antibody-drug Conjugates Market Share by Manufacturer: Here, production, revenue, and price analysis by the manufacturer are included along with other chapters such as expansion plans and merger and acquisition, products offered by key manufacturers, and areas served and headquarters distribution.
    • Market Size by Type: It includes analysis of price, production value market share, and production market share by type.
    • Market Size by Application: This section includes Antibody-drug Conjugates market consumption analysis by application.
    • Profiles of Manufacturers: Here, leading players of the Antibody-drug Conjugates market are studied based on sales area, key products, gross margin, revenue, price, and production.
    • Antibody-drug Conjugates Market Value Chain and Sales Channel Analysis: It includes customer, distributor, Antibody-drug Conjugates market value chain, and sales channel analysis.
    • Market Forecast – Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

    Get More Information @ https://www.marketresearchintellect.com/product/global-antibody-drug-conjugates-market-size-and-forecast/

    Thank you for reading our report. Please contact us to learn more about the report and the customization options. Our team will ensure that the report meets your requirements.

    About Us:

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

    Contact Us:

    Mr. Steven Fernandes

    Market Research Intellect

    New Jersey ( USA )

    Tel: +1-650-781-4080

    Website – https://www.marketresearchintellect.com/

  • Categories
    All News

    Antibody Drug Conjugates Market Size 2020 | Analysis, Trends, Top Manufacturers, Growth, Scope, Opportunities and Forecast to 2027

    New Jersey, United States,- The Antibody Drug Conjugates Market report provides an in-depth analysis of the current and future state of the Antibody Drug Conjugates industry. The Antibody Drug Conjugates Market Report presents emerging trends and market dynamics regarding drivers, opportunities, and challenges. The report covers the details of suppliers, consumers, and the level of competition. It also includes Antibody Drug Conjugates Market Size, Revenue, Share, Industry Growth Rate, and Revenue. The Antibody Drug Conjugates market report has an essential list of key aspects of Antibody Drug Conjugates that includes leading market players along with their profiles and key financial data.

    The most recent Antibody Drug Conjugates market report has extensive documentation of this industry while also showing the consumption and production patterns. The report provides information on key drivers, challenges, threats, and opportunities that are influencing market dynamics. It also includes Porter’s Five Forces Analysis to examine the industry’s competitive matrix.

    The study draws attention to various trading tactics that can be used to generate returns. However, due to the recent COVID-19 outbreak, the market will have some uncertainties. The research, therefore, focuses on the impact of the coronavirus pandemic on the industry scenario over the forecast period and suggests a coping mechanism for better results.

    The report provides an in-depth analysis of the major market players along with their business overview, expansion plans, and strategies. The main actors examined in the report are:

  • F. Hoffman-la Roche
  • Novartis Ag
  • Takeda Pharmaceutical
  • Pfizer
  • Seattle Genetics
  • Genentech
  • Immunogen
  • Progenics Pharmaceuticals
  • Bayer Healthcare Pharmaceuticals

    The report covers the global Antibody Drug Conjugates Market size in terms of value chain, production and consumption quota. The report considers 2017-2018 as historical years, 2019 as the base year and the forecast calendar 2020-2027. It also covers the market breakdown in terms of top manufacturers, key regions, types of products offered in the market and range of applications.

    Antibody Drug Conjugates Market by Type Segments:

  • Adcetris
  • Kadcyla

    Antibody Drug Conjugates Market by Application Segments:

  • Breast Cancer
  • Lymphoma

    Antibody Drug Conjugates Market by Regional Segments:

    The chapter on regional segmentation details the regional aspects of the Antibody Drug Conjugates market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and anticipates its influence on the Antibody Drug Conjugates market.

    • The Middle East and Africa (GCC Countries and Egypt)
    • North America (the United States, Mexico, and Canada)
    • South America (Brazil etc.)
    • Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
    • Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

    Report Highlights

    • Comprehensive pricing analysis on the basis of product, application, and regional segments
    • The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the Antibody Drug Conjugates market
    • Deep insights about regulatory and investment scenarios of the Antibody Drug Conjugates market
    • Analysis of market effect factors and their impact on the forecast and outlook of the Antibody Drug Conjugates market
    • A roadmap of growth opportunities available in the Antibody Drug Conjugates market with the identification of key factors
    • The exhaustive analysis of various trends of the Antibody Drug Conjugates market to help identify market developments

    Table of Contents

    • Report Overview: It includes six chapters, viz. research scope, major manufacturers covered, market segments by type, Antibody Drug Conjugates market segments by application, study objectives, and years considered.
    • Global Growth Trends: There are three chapters included in this section, i.e. industry trends, the growth rate of key producers, and production analysis.
    • Antibody Drug Conjugates Market Share by Manufacturer: Here, production, revenue, and price analysis by the manufacturer are included along with other chapters such as expansion plans and merger and acquisition, products offered by key manufacturers, and areas served and headquarters distribution.
    • Market Size by Type: It includes analysis of price, production value market share, and production market share by type.
    • Market Size by Application: This section includes Antibody Drug Conjugates market consumption analysis by application.
    • Profiles of Manufacturers: Here, leading players of the Antibody Drug Conjugates market are studied based on sales area, key products, gross margin, revenue, price, and production.
    • Antibody Drug Conjugates Market Value Chain and Sales Channel Analysis: It includes customer, distributor, Antibody Drug Conjugates market value chain, and sales channel analysis.
    • Market Forecast – Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

    Get More Information @ https://www.marketresearchintellect.com/product/global-antibody-drug-conjugates-market-size-and-forcast/

    Thank you for reading our report. Please contact us to learn more about the report and the customization options. Our team will ensure that the report meets your requirements.

    About Us:

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

    Contact Us:

    Mr. Steven Fernandes

    Market Research Intellect

    New Jersey ( USA )

    Tel: +1-650-781-4080

    Website – https://www.marketresearchintellect.com/

  • Categories
    News

    Antibody-drug Conjugates Market Executive Summary, Introduction, Sizing, Analysis and Forecast To 2025

    Antibody-drug Conjugates Market Forecast 2020-2026

    The Global Antibody-drug Conjugates Market research report provides and in-depth analysis on industry- and economy-wide database for business management that could potentially offer development and profitability for players in this market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. It offers critical information pertaining to the current and future growth of the market. It focuses on technologies, volume, and materials in, and in-depth analysis of the market. The study has a section dedicated for profiling key companies in the market along with the market shares they hold.

    The report consists of trends that are anticipated to impact the growth of the Antibody-drug Conjugates Market during the forecast period between 2020 and 2026. Evaluation of these trends is included in the report, along with their product innovations.

    Get a PDF Copy of the Sample Report for free @ https://www.upmarketresearch.com/home/requested_sample/50062

    The Report Covers the Following Companies:
    ImmunoGen
    Seattle Genetics
    Roche
    Takeda

    By Types:
    Adcetris
    Kadcyla

    By Applications:
    Breast Cancer
    Lymphoma

    Furthermore, the report includes growth rate of the global market, consumption tables, facts, figures, and statistics of key segments.

    By Regions:

    • North America (The US, Canada, and Mexico)
    • Europe (Germany, France, the UK, and Rest of the World)
    • Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
    • Latin America (Brazil and Rest of Latin America.)
    • Middle East & Africa (Saudi Arabia, the UAE, , South Africa, and Rest of Middle East & Africa)

    Grab Your Report at an Impressive Discount! Please click here @ https://www.upmarketresearch.com/home/request_for_discount/50062

    Years Considered to Estimate the Market Size:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year: 2020-2026

    Important Facts about Antibody-drug Conjugates Market Report:

    • This research report encompasses Antibody-drug Conjugates Market overview, market share, demand and supply ratio, supply chain analysis, and import/export details.
    • The report has different approaches and procedures endorsed by Key Market players that enable efficient business decisions.
    • The report offers information such as production value, strategies adopted by market players and products/services they provide.

    What Our Report Offers:

    • Market share valuations of the segments on country and global level
    • Share analysis of the major market players
    • Opportunities for new market entrants
    • Market forecast for a minimum of 6 years for all the segments, sub-segments in various countries and regions
    • Market Trends (drivers, restraints, opportunities, threats, challenges, investment opportunities, and approvals)
    • Strategic endorsements in key business segments on the basis of market valuations
    • Competitive scenario mapping the key development patterns.
    • Company profiling with comprehensive strategies, financial details, and recent progressions.
    • Supply chain trends representing the latest technological advancements.

    Make an Inquiry of This Report @ https://www.upmarketresearch.com/home/enquiry_before_buying/50062

    About UpMarketResearch:
    Up Market Research (https://www.upmarketresearch.com) is a leading distributor of market research report with more than 800+ global clients. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

    Contact Info –
    UpMarketResearch
    Name – Alex Mathews
    Email – [email protected]
    Organization – UpMarketResearch
    Address – 500 East E Street, Ontario, CA 91764, United States.